Key Takeaways The New York Times Company (NYT) continued its strong performance in the fourth quarter of 2025, with results surpassing expectations for both the top and bottom lines. Adjusted earnings came in at 89 cents a share, topping the Zacks Consensus Estimate of 88 cents and improving from 80 cents in the prior-year quarter. Revenues rose 10.4% year over year to $802.3 million, outpacing the Zacks Consensus Estimate of $790 million. Total subscription revenues climbed 9.4% year over year to $510.5 mi ...

Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days. For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Prem ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? Developed ...

The Style Scores are broken down into four categories: Value Score Value investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks. Growth Score For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium pr ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style ...

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of CoreWeave, Inc. (“CoreWeave” or the “Company”) (NASDAQ: CRWV) between March 28, 2025 and December 15, 2025, inclusive. Should You Join The CoreWeave Class Action Lawsuit? Do you, or did you, own shares of CoreWeave, Inc. (NASDAQ: CRWV)?Did you purchase your shares between March 28, 2025 and ...

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Beyond Meat, Inc. (“Beyond Meat” or the “Company”) (NASDAQ: BYND) between February 27, 2025 through November 11, 2025, inclusive (collectively, the “Class Period”). Should You Join The Beyond Meat Class Action Lawsuit: Do you, or did you, own shares of Beyond Meat, Inc. (NASDAQ: BYND)?Did y ...

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Vistagen Therapeutics, Inc. (“Vistagen” or the “Company”) (NASDAQ: VTGN) between April 1, 2024 and December 16, 2025, inclusive. Should You Join The Vistagen Class Action Lawsuit? Do you, or did you, own shares of Vistagen Therapeutics, Inc. (NASDAQ: VTGN)?Did you purchase your shares bet ...

Bagsværd, Denmark and Plainsboro, NJ, 5 February 2026 – Novo Nordisk today issued the following statement regarding the announcement by Hims & Hers that they will unlawfully mass-market an unapproved, inauthentic, and untested knockoff semaglutide pill. “The action by Hims & Hers is illegal mass compounding that poses a significant risk to patient safety. Novo Nordisk will take legal and regulatory action to protect patients, our intellectual property and the integrity of the US gold-standard drug approval ...

InterDigital (IDCC) came out with quarterly earnings of $2.12 per share, beating the Zacks Consensus Estimate of $1.65 per share. This compares to earnings of $5.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +28.74%. A quarter ago, it was expected that this wireless research and development company would post earnings of $1.79 per share when it actually produced earnings of $2.55, delivering a surprise of +42.46%.Over the ...